Search research articles
Contact Us
Filters
Showing results (221-230 of 277) with videos related to
Page
of 28
Sort By:
Science Signaling
|
August 16, 2018
Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins
Sirish K Ippagunta, Julie A Pollock, Naina Sharma, et al.
Science Translational Medicine
|
January 23, 2015
Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis
Yuechao Zhao, Ping Gong, Yiru Chen, et al.
Journal of the American Chemical Society
|
October 31, 2024
Iterative Catalyst-Controlled Diastereoselective Matteson Homologations Enable the Selective Synthesis of Benzestrol Isomers
Samantha R Angle, Hayden A Sharma, Christie K Choi, et al.
Brain Pathology (Zurich, Switzerland)
|
December 28, 2020
Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis
Maria T Sekyi, Kelli Lauderdale, Kelley C Atkinson, et al.
Journal of Medicinal Chemistry
|
June 29, 2017
Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer Cells
Jian Min, Valeria Sanabria Guillen, Abhishek Sharma, et al.
Molecular and Cellular Endocrinology
|
February 1, 2020
The tissue-specific effects of different 17β-estradiol doses reveal the key sensitizing role of AF1 domain in ERα activity
Coralie Fontaine, Melissa Buscato, Alexia Vinel, et al.
Endocrinology
|
August 22, 2019
Differential Actions of Estrogen Receptor α and β via Nongenomic Signaling in Human Prostate Stem and Progenitor Cells
Shyama Majumdar, Jaqueline C Rinaldi, Neha R Malhotra, et al.
Science Signaling
|
May 26, 2016
Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues
Zeynep Madak-Erdogan, Sung Hoon Kim, Ping Gong, et al.
Science Advances
|
September 2, 2022
Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling
Miriam Doepner, Inyoung Lee, Christopher A Natale, et al.
ACS Pharmacology & Translational Science
|
August 14, 2025
Benzestrol Isomer Stereochemistry Determines the Distinct Estrogenic Activities and Conformations of the Eight Isomers When Bound to Estrogen Receptor α
Yingwei Hou, Jerome C Nwachukwu, Kathryn Carlson, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 277) with videos related to
Sort By:
Page
of 28
Science Signaling
|
August 16, 2018
Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins
Sirish K Ippagunta, Julie A Pollock, Naina Sharma, et al.
Science Translational Medicine
|
January 23, 2015
Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis
Yuechao Zhao, Ping Gong, Yiru Chen, et al.
Journal of the American Chemical Society
|
October 31, 2024
Iterative Catalyst-Controlled Diastereoselective Matteson Homologations Enable the Selective Synthesis of Benzestrol Isomers
Samantha R Angle, Hayden A Sharma, Christie K Choi, et al.
Brain Pathology (Zurich, Switzerland)
|
December 28, 2020
Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis
Maria T Sekyi, Kelli Lauderdale, Kelley C Atkinson, et al.
Journal of Medicinal Chemistry
|
June 29, 2017
Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer Cells
Jian Min, Valeria Sanabria Guillen, Abhishek Sharma, et al.
Molecular and Cellular Endocrinology
|
February 1, 2020
The tissue-specific effects of different 17β-estradiol doses reveal the key sensitizing role of AF1 domain in ERα activity
Coralie Fontaine, Melissa Buscato, Alexia Vinel, et al.
Endocrinology
|
August 22, 2019
Differential Actions of Estrogen Receptor α and β via Nongenomic Signaling in Human Prostate Stem and Progenitor Cells
Shyama Majumdar, Jaqueline C Rinaldi, Neha R Malhotra, et al.
Science Signaling
|
May 26, 2016
Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues
Zeynep Madak-Erdogan, Sung Hoon Kim, Ping Gong, et al.
Science Advances
|
September 2, 2022
Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling
Miriam Doepner, Inyoung Lee, Christopher A Natale, et al.
ACS Pharmacology & Translational Science
|
August 14, 2025
Benzestrol Isomer Stereochemistry Determines the Distinct Estrogenic Activities and Conformations of the Eight Isomers When Bound to Estrogen Receptor α
Yingwei Hou, Jerome C Nwachukwu, Kathryn Carlson, et al.
Page
of 28